Or previous abnormal PSA result, taking into consideration their life expectancy in relation to the likelyĬourse of prostate cancer, as part of the decision-making process Testing may be appropriate in asymptomatic males aged over 70 years, e.g.discuss the benefitsĪnd risks of PSA testing and the role of digital rectal examination (DRE) and refer them to patient information developed If asymptomatic males aged 50–70 years (or from age 40 years in those with a family history) enquire about testingįor prostate cancer, provide information so they can make an informed decision, i.e.In addition, not all males with prostate cancer have Of results can be difficult as elevated PSA levels are not specific for cancer and can be caused by otherĬonditions such as benign prostatic hyperplasia and prostatitis. Prostate-specific antigen (PSA) is the only widely available test for detecting prostate cancer.To reduced access to healthcare and delayed diagnosis

Māori are approximately twice as likely to die following a diagnosis of prostate cancer than non-Māori, likely due.Those with a family history of prostate cancer are at the greatest risk. Prostate cancer is the third highest cause of cancer death for New Zealand males, behind lung and colorectal cancers.If you would like to know what changes were made when the article was updated please contact us 14 February 2020 - Footnote about referral time frames added to Table 3Ħ March 2020 - Added new sidebar: The role of DRE - a discussion

Need username and password for pyroseta